Perspective Therapeutics, Inc. (CATX)
NYSEAMERICAN: CATX · Real-Time Price · USD
2.340
+0.100 (4.46%)
Oct 15, 2026, 4:00 PM EDT - Market closed
Perspective Therapeutics Stock Forecast
CATX's stock price has decreased by -51.65% in the past year and price targets may not have had time to catch up.
Stock Price Forecast
According to 16 analysts polled by S&P Global, Perspective Therapeutics stock has a consensus rating of "Strong Buy" and an average price target of $12.29. The average 1-year stock price forecast is 425.21% higher than the current stock price, while the lowest is $5.00 (+113.68%) and the highest is $18 (+669.23%).
Price Target: $12.29 (+425.21%)
Analyst Consensus: Strong Buy
Price Target
ChartAnalyst Ratings
The average analyst rating for Perspective Therapeutics stock is "Strong Buy". This means that analysts believe this stock is likely to perform very well in the near future and significantly outperform the market.
Recommendation Trends
| Rating | May '26 | Jun '26 | Jul '26 | Aug '26 | Sep '26 | Oct '26 |
|---|---|---|---|---|---|---|
| Strong Buy | 12 | 12 | 12 | 12 | 13 | 13 |
| Buy | 2 | 2 | 2 | 2 | 2 | 2 |
| Hold | 1 | 1 | 1 | 1 | 1 | 1 |
| Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Strong Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Total | 15 | 15 | 15 | 15 | 16 | 16 |
Latest Forecasts
| Analyst | Firm | Rating | Rating | Action | Price Target | Upside | Date |
|---|---|---|---|---|---|---|---|
| Truist Financial | Truist Financial | Buy Maintains $11 | Buy | Maintains | $11 | +370.09% | Oct 13, 2026 |
Unknown Analyst Wedbush No rating | Wedbush | Buy Maintains $11 | Buy | Maintains | $11 | +370.09% | Oct 13, 2026 |
| UBS | UBS | Buy Maintains $8 | Buy | Maintains | $8 | +241.88% | Oct 3, 2026 |
| William Blair | William Blair | Buy Initiates n/a | Buy | Initiates | n/a | n/a | Sep 18, 2026 |
| BMO Capital | BMO Capital | Buy Maintains $11 | Buy | Maintains | $11 | +370.09% | Sep 15, 2026 |
Financial Forecast
Revenue This Year
299.00K
from 884.00K
Decreased by -66.18%
Revenue Next Year
299.17K
from 299.00K
Increased by 0.06%
EPS This Year
-0.99
from -1.40
EPS Next Year
-1.02
from -0.99
EPS and Forward PE are based on non-GAAP adjusted numbers.